Medical Marijuana News

Medical cannabis patients in New Jersey can now receive doctor recommendations for the program online through the use of telemedicine services.

A New Jersey doctor has had his license suspended after officials accused him of “indiscriminately” authorizing medical cannabis for “thousands of patients.”

A great-grandmother is suing Disney after she was arrested at the company’s Florida theme park last year for carrying hemp-derived CBD oil, which is legal under federal law.

A recent survey of millennial and baby boomer cannabis consumers suggests that baby boomers use cannabis for medicinal purposes at twice the rate of millennials.

The University of Pittsburgh has announced a 10-year research program with medical cannabis company Parallel (formerly Surterra Wellness).

The FDA has expanded the label of Epidiolex, the first CBD-based medication approved by the federal agency, to treat seizures resulting from tuberous sclerosis complex.

Veteran Sean Worsley stopped for gas in Gordo, Alabama to pump gas for his wife on a family road trip to his grandmother’s house. While pumping gas he was laughing and playing air guitar. He was approached by Gordo PD for violating a noise ordinance with his music, and the events that unfolded from there would change his life forever.

A Delaware court has rejected an injured employee’s request for his former employee to compensate him for medical cannabis expenses related to his injury.

An additional 350 Missouri cannabis patients have been identified as having received fake physician certifications for the state’s medical cannabis program; the scheme has affected about 1,000 patients, so far.

Thailand is allowing hospitals to produce traditional medicines that contain cannabis, as long as an expert in traditional Thai medicines is on duty to prepare them.

Four New Mexico medical cannabis brands are accusing the state of adopting “arbitrary and capricious” rules, some of which appear to be copy-pasted from other states including a testing requirement for mycotoxins which have never been found in New Mexico-grown cannabis.

New research from the University of California, Irvine has determined that cannabis is a safe and potentially effective treatment for the chronic pain associated with sickle cell disease.

Australia’s National Drug Strategy Household Survey found that just 3.9 percent of Australians who used medical cannabis last year obtained it legally via a prescription.

Medical cannabis firm Ultra Health is asking a district court judge to invalidate new cannabis testing, labeling, and facility safety rules in New Mexico, calling them “arbitrary and capricious.”

Nebraskans for Medical Marijuana have submitted over 182,000 signatures in support of a statewide legalization ballot initiative; the campaign only needs 121,000 of those signatures to be validated to secure the initiative’s spot on the ballot.

A new proposal in Pennsylvania aims to eliminate zero-tolerance driving rules for registered cannabis patients; the current rules effectively block patients from driving as THC can stay in one’s system for up to 30 days.

Cann Group in Victoria, Australia has secured a government-funded jobs grant for $1.97 million to upgrade its cultivation/production facility, which could generate 150 local jobs.

Despite legalizing more than 18 months ago, the UK National Health Services has yet to issue a single government-funded prescription for medical cannabis.

A recent survey of more than 1,450 CBD consumers revealed that most use CBD to treat chronic pain, and 84% believe CBD is an effective replacement for opioids.

Curaleaf announced it is expanding its Select vaporizers brand into four new state markets: Maine, Massachusetts, Ohio, and Florida.

Under new rules linked to the coronavirus pandemic, New Jersey medical cannabis dispensaries can now apply to be able to offer delivery services.

The U.S. Defense Advanced Research Projects Agency is funding a medical health study into the therapeutic use of psychedelics such as ketamine and psilocybin.

Medical cannabis firms in Oklahoma have filed suit against the state over new industry residency requirements and other rules which will spell trouble for some licensees who are already operating in the state.

Some 600 medical cannabis patients in Missouri could lose access to the program after state regulators realized the applicants’ physician certification forms were submitted with an unauthorized signature.